SCHEMBL4948828

SCHEMBL4948828

O=C(COc1cccc(F)c1)N1CCC2(CC1)C(=O)Nc1ccccc12

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 3/20 0.49
LMNA P02545 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
HTR1A P08908 3/20 0.44
HTR2A P28223 3/20 0.44
HTR7 P34969 3/20 0.44
HTR6 P50406 3/20 0.44
ALDH1A1 P00352 3/20 0.44
TSHR P16473 1/20 0.44
AKR1A1 P14550 1/20 0.44
AKR1B1 P15121 1/20 0.44
OPRM1 P35372 1/20 0.43
OPRK1 P41145 1/20 0.43
OPRL1 P41146 1/20 0.43
PDK2 Q15119 3/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4949410 0.89 FKBP1A (0.52) ENPP2LMNASMN1; SMN2KMT2AMEN1
SCHEMBL4951646 0.88 MEN1 (0.58) LMNASMN1; SMN2KMT2AMEN1HTR1A
SCHEMBL13996727 0.88 RECQL (0.44) LMNASMN1; SMN2KMT2AMEN1HTR1A
SCHEMBL4948679 0.88 MEN1 (0.44) LMNANPSR1KMT2AMEN1HTR1A
SCHEMBL4952809 0.88 GAA (0.57) LMNASMN1; SMN2NPSR1KMT2AMEN1
SCHEMBL4952558 0.88 FKBP1A (0.56) ENPP2KMT2AMEN1HTR1AHTR2A
SCHEMBL4953381 0.87 ALDH1A1 (0.56) ENPP2LMNASMN1; SMN2KMT2AMEN1
SCHEMBL13996616 0.86 MEN1 (0.43) KMT2AMEN1HTR1AHTR2AHTR7
SCHEMBL4955662 0.85 NPC1 (0.60) LMNASMN1; SMN2KMT2AMEN1ALDH1A1
SCHEMBL4954092 0.85 ATF4 (0.56) HTR1AHTR2AHTR7HTR6PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME KOWA CO., LTD. (JP) 2008-12-11 US disclosed
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME KOWA CO., LTD. (JP) 2008-12-11 US disclosed
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME KOWA CO., LTD. (JP) 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME HSD11B1, HSD11B2, HSD3B1 ENPP2 3541/4885LMNA 2737/4885SMN1; SMN2 4428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.